Regulation of hippocampal and behavioral excitability by cyclin-dependent kinase 5

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Hawasli, Ammar H ^a   Koovakkattu, Della ^b   Hayashi, Kanehiro ^a   Anderson, Anne E ^c   Powell, Craig M ^a,b   Sinton, Christopher M ^b   Bibb, James A ^a   Cooper, Donald C ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; HYDROXYTAMOXIFEN; MAGNESIUM ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN P25; ANTICONVULSIVE AGENT; MAGNESIUM;

ANIMAL EXPERIMENT; ARTICLE; AUDIOGENIC SEIZURE; CHEMICAL ANALYSIS; CONTROLLED STUDY; EPILEPTIC DISCHARGE; EPILEPTIC STATE; HIPPOCAMPUS; HOMEOSTASIS; MOUSE; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NONHUMAN; POST TETANIC POTENTIATION; POSTSYNAPTIC INHIBITION; POSTSYNAPTIC POTENTIAL; PROTEIN FUNCTION; SEIZURE; SPIKE WAVE; STARTLE REFLEX; SYNAPTIC TRANSMISSION; ANIMAL; ANIMAL BEHAVIOR; BIOLOGICAL MODEL; C57BL MOUSE; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; GENE EXPRESSION REGULATION; MALE; METABOLISM; METHODOLOGY; MOUSE MUTANT; NEUROLOGIC DISEASE; PHYSIOLOGY;

ANIMALIA; MUS;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; CYCLIN-DEPENDENT KINASE 5; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MAGNESIUM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES;

EID: 67149131566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005808     Document Type: Article

References (70)

1. Benavides DR, Quinn JJ, Zhong P, Hawasli AH, DiLeone RJ, et al. (2007) Cdk5 modulates cocaine reward, motivation, and striatal neuron excitability. J Neurosci 27: 12967-12976.
2. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, et al. (2001) Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410: 376-380.
3. Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, et al. (1999) Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402: 669-671.
4. Cheung ZH, Fu AKY, Ip NY (2006) Synaptic Roles of Cdk5: Implications in Higher Cognitive Functions and Neurodegenerative Diseases. Neuron 50: 13-18.
5. Fischer A, Sananbenesi F, Pang PT, Lu B, Tsai LH (2005) Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 48: 825-838.
6. Gilmore EC, Ohshima T, Goffinet AM, Kulkarni AB, Herrup K (1998) Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex. J Neurosci 18: 6370-6377.
7. Hawasli AH, Benavides DR, Nguyen C, Kansy JW, Hayash K, et al. (2007) Cyclin-dependent kinase 5 governs learning and synaptic plasticity via regulation of NMDA receptor degradation. Nature Neuroscience 10: 880-886.
8. Lagace DC, Benavides DR, Kansy JW, Mapelli M, Greengard P, et al. (2008) Cdk5 is essential for adult hippocampal neurogenesis. Proc Natl Acad Sci U S A 105: 18567-18571.
9. Meyer DA, Richer E, Benkovic SA, Hayashi K, Kansy JW, et al. (2008) Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology. Proc Natl Acad Sci U S A 105: 18561-18566.
10. Ohshima T, Ogura H, Tomizawa K, Hayashi K, Suzuki H, et al. (2005) Impairment of hippocampal long-term depression and defective spatial learning and memory in p35 mice. J Neurochem 94: 917-925.
11. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, et al. (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A 93: 11173-11178.
12. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, et al. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402: 615-622.
13. Sahin B, Hawasli AH, Greene RW, Molkentin JD, Bibb JA (2008) Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C. Eur J Pharmacol 581: 270-275.
14. Wei FY, Tomizawa K, Ohshima T, Asada A, Saito T, et al. (2005) Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J Neurochem 93: 502-512.
15. Hawasli AH, Bibb JA (2007) Alternative roles for Cdk5 in learning and synaptic plasticity. Biotechnol J 2: 941-948.
16. Sananbenesi F, Fischer A, Wang X, Schrick C, Neve R, et al. (2007) A hippocampal Cdk5 pathway regulates extinction of contextual fear. Nat Neurosci 10: 1012-1019.
17. Fischer A, Sananbenesi F, Schrick C, Spiess J, Radulovic J (2002) Cyclin-dependent kinase 5 is required for associative learning. J Neurosci 22: 3700-3707.
18. Bibb JA (2003) Role of Cdk5 in neuronal signaling, plasticity, and drug abuse. Neurosignals 12: 191-199.
19. Cruz JC, Tsai LH (2004) Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol Med 10: 452-458.
20. Simpkins KL, Guttmann RP, Dong Y, Chen Z, Sokol S, et al. (2003) Selective activation induced cleavage of the NR2B subunit by calpain. J Neurosci 23: 11322-11331.
21. Yan Z, Chi P, Bibb JA, Ryan TA, Greengard P (2002) Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons. J Physiol 540: 761-770.
22. Buraei Z, Schofield G, Elmslie KS (2007) Roscovitine differentially affects CaV2 and Kv channels by binding to the open state. Neuropharmacology 52: 883-894.
23. Powell CM, Schoch S, Monteggia L, Barrot M, Matos MF, et al. (2004) The presynaptic active zone protein RIM1alpha is critical for normal learning and memory. Neuron 42: 143-153.
24. Weber P, Metzger D, Chambon P (2001) Temporally controlled targeted somatic mutagenesis in the mouse brain. Eur J Neurosci 14: 1777-1783.
25. Kramar EA, Lin B, Lin CY, Arai AC, Gall CM, et al. (2004) A novel mechanism for the facilitation of theta-induced long-term potentiation by brain-derived neurotrophic factor. J Neurosci 24: 5151-5161.
26. Kamiya H, Zucker RS (1994) Residual Ca2+ and short-term synaptic plasticity. Nature 371: 603-606.
27. McNamara JO, Huang YZ, Leonard AS (2006) Molecular signaling mechanisms underlying epileptogenesis. Sci STKE 2006: re12.
28. Ohmori H, Sato Y, Namiki A (2004) The anticonvulsant action of propofol on epileptiform activity in rat hippocampal slices. Anesth Analg 99: 1095-1101. table of contents.
29. Pitkanen A, Schwartzhroin PA, Moshe SL (2006) Models of Seizures and Epilepsy. Oxford: Elsevier. 687 p.
30. Baulac S, Gourfinkel-An I, Picard F, Rosenberg-Bourgin M, Prud'homme JF, et al. (1999) A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am J Hum Genet 65: 1078-1085.
31. Escayg A, Heils A, MacDonald BT, Haug K, Sander T, et al. (2001) A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus - nd prevalence of variants in patients with epilepsy. Am J Hum Genet 68: 866-873.
32. Escayg A, MacDonald BT, Meisler MH, Baulac S, Huberfeld G, et al. (2000) Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 24: 343-345.
33. Wallace RH, Wang DW, Singh R, Scheffer IE, George AL Jr, et al. (1998) Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet 19: 366-370.
34. Madeja M (2000) Do neurons have a reserve of sodium channels for the generation of action potentials? A study on acutely isolated CA1 neurons from the guinea-pig hippocampus. Eur J Neurosci 12: 1-7.
35. Fisher RS, Coyle JT (1991) Neurotransmitters and epilepsy. New York: Wiley-Liss.
36. Mulley JC, Scheffer IE, Petrou S, Berkovic SF (2003) Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 16: 171-176.
37. Hardingham GE, Bading H (2003) The Yin and Yang of NMDA receptor signalling. Trends Neurosci 26: 81-89.
38. Sen A, Thom M, Martinian L, Jacobs T, Nikolic M, et al. (2006) Deregulation of cdk5 in Hippocampal sclerosis. J Neuropathol Exp Neurol 65: 55-66.
39. Fochtmann LJ (1994) Animal studies of electroconvulsive therapy: foundations for future research. Psychopharmacol Bull 30: 321-444.
40. Swinyard EA (1972) Electrically induced convulsions. In: Experimental Models of Epilepsy. Purpura DP, Penry D, Tower DW, DM, Walter R, eds. New York: Raven Press. pp 433-458.
41. Fletcher AI, Shuang R, Giovannucci DR, Zhang L, Bittner MA, et al. (1999) Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18. J Biol Chem 274: 4027-4035.
42. Shuang R, Zhang L, Fletcher A, Groblewski GE, Pevsner J, et al. (1998) Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings. J Biol Chem 273: 4957-4966.
43. Tomizawa K, Ohta J, Matsushita M, Moriwaki A, Li ST, et al. (2002) Cdk5/ p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J Neurosci 22: 2590-2597.
44. Cheng K, Ip NY (2003) Cdk5: a new player at synapses. Neurosignals 12: 180-190.
45. Evans GJ, Cousin MA (2007) Activity-dependent control of slow synaptic vesicle endocytosis by cyclin-dependent kinase 5. J Neurosci 27: 401-411.
46. Graham ME, Anggono V, Bache N, Larsen MR, Craft GE, et al. (2007) The in vivo phosphorylation sites of rat brain dynamin I. J Biol Chem 282: 14695-14707.
47. Liang S, Wei FY, Wu YM, Tanabe K, Abe T, et al. (2007) Major Cdk5-dependent phosphorylation sites of amphiphysin 1 are implicated in the regulation of the membrane binding and endocytosis. J Neurochem.
48. Tan TC, Valova VA, Malladi CS, Graham ME, Berven LA, et al. (2003) Cdk5 is essential for synaptic vesicle endocytosis. Nat Cell Biol 5: 701-710.
49. Mikuni N, Babb TL, Ying Z, Najm I, Nishiyama K, et al. (1999) NMDA-receptors 1 and 2A/B coassembly increased in human epileptic focal cortical dysplasia. Epilepsia 40: 1683-1687.
50. Moddel G, Jacobson B, Ying Z, Janigro D, Bingaman W, et al. (2005) The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia. Brain Res 1046: 10-23.
51. Najm IM, Ying Z, Babb T, Mohamed A, Hadam J, et al. (2000) Epileptogenicity correlated with increased N-methyl-D-aspartate receptor subunit NR2A/B in human focal cortical dysplasia. Epilepsia 41: 971-976.
52. Ying Z, Bingaman W, Najm IM (2004) Increased numbers of coassembled PSD-95 to NMDA-receptor subunits NR2B and NR1 in human epileptic cortical dysplasia. Epilepsia 45: 314-321.
53. Sisodiya SM, Thom M, Lin WR, Bajaj NP, Cross JH, et al. (2002) Abnormal expression of cdk5 in focal cortical dysplasia in humans. Neurosci Lett 328: 217-220.
54. Sen A, Thom M, Martinian L, Yogarajah M, Nikolic M, et al. (2007) Increased immunoreactivity of cdk5 activators in hippocampal sclerosis. Neuroreport 18: 511-516.
55. Chae T, Kwon YT, Bronson R, Dikkes P, Li E, et al. (1997) Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18: 29-42.
56. Patel LS, Wenzel HJ, Schwartzkroin PA (2004) Physiological and morphological characterization of dentate granule cells in the p35 knock-out mouse hippocampus: evidence for an epileptic circuit. J Neurosci 24: 9005-9014.
57. Wenzel HJ, Robbins CA, Tsai LH, Schwartzkroin PA (2001) Abnormal morphological and functional organization of the hippocampus in a p35 mutant model of cortical dysplasia associated with spontaneous seizures. J Neurosci 21: 983-998.
58. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, et al. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405: 360-364.
59. Ketelaars SO, Gorter JA, van Vliet EA, Lopes da Silva FH, Wadman WJ (2001) Sodium currents in isolated rat CA1 pyramidal and dentate granule neurones in the post-status epilepticus model of epilepsy. Neuroscience 105: 109-120.
60. Arroyo S, Brodie MJ, Avanzini G, Baumgartner C, Chiron C, et al. (2002) Is refractory epilepsy preventable? Epilepsia 43: 437-444.
61. Cooper DC, Chung S, Spruston N (2005) Output-mode transitions are controlled by prolonged inactivation of sodium channels in pyramidal neurons of subiculum. PLoS Biol 3: e175.
62. Fowler MA, Sidiropoulou K, Ozkan ED, Phillips CW, Cooper DC (2007) Corticolimbic Expression of TRPC4 and TRPC5 Channels in the Rodent Brain. PLoS ONE 2: e573.
63. Lauterborn JC, Rex CS, Kramar E, Chen LY, Pandyarajan V, et al. (2007) Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. J Neurosci 27: 10685-10694.
64. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437-451.
65. Racine RJ (1972) Modification of seizure activity by electrical stimulation. I. After-discharge threshold. Electroencephalogr Clin Neurophysiol 32: 269-279.
66. Shah MM, Anderson AE, Leung V, Lin X, Johnston D (2004) Seizure-induced plasticity of h channels in entorhinal cortical layer III pyramidal neurons. Neuron 44: 495-508.
67. Geyer MA, Dulawa SC (2003) Current Protocols in Neuroscience, In: Jacqueline Crawley CG, Michael Rogawski, David Sibley, Phil Skolnick, Susan Wray, Ron McKay, Gwen Taylor, eds. John Wiley & Sons, Inc.
68. Blundell J, Tabuchi K, Bolliger MF, Blaiss CA, Brose N, et al. (2009) Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2. Genes Brain Behav 8: 114-126.
69. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, et al. (2006) Pten regulates neuronal arborization and social interaction in mice. Neuron 50: 377-388.
70. Gold SJ, Heifets BD, Pudiak CM, Potts BW, Nestler EJ (2002) Regulation of regulators of G protein signaling mRNA expression in rat brain by acute and chronic electroconvulsive seizures. J Neurochem 82: 828-838.